CN110551117B - Phenazine compound containing oxazole ring and application of phenazine compound as agricultural bactericide - Google Patents
Phenazine compound containing oxazole ring and application of phenazine compound as agricultural bactericide Download PDFInfo
- Publication number
- CN110551117B CN110551117B CN201910956284.4A CN201910956284A CN110551117B CN 110551117 B CN110551117 B CN 110551117B CN 201910956284 A CN201910956284 A CN 201910956284A CN 110551117 B CN110551117 B CN 110551117B
- Authority
- CN
- China
- Prior art keywords
- phenazine
- compound
- oxazole ring
- oxazole
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/76—1,3-Oxazoles; Hydrogenated 1,3-oxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
The invention relates to a kind of thiophene containing oxazole ringOxazine compounds and the use of such compounds as agricultural fungicides. The compounds have the following general formula:
Description
Technical Field
The invention relates to a phenazine compound containing an oxazole ring and application thereof as a bactericide in plant disease control, belonging to the technical field of agricultural pharmacy.
Background
The natural phenazine compound is a secondary metabolite widely existing in microorganisms such as pseudomonas and streptomyces, and has different physical and chemical properties and multiple biological activities such as antibiosis, nematode resistance, antimalarial resistance, antioxidation, hypertension resistance, cell proliferation inhibition and the like due to different types and positions of functional groups on a phenazine ring. In the agricultural field, the agricultural antibiotic-shenqinmycin which is independently researched and developed in China is a phenazine compound generated by the metabolism of pseudomonas, has been registered as a pesticide at present, and is applied to the control of plant diseases such as gummy stem blight, root rot and the like.
Oxazole ring is a functional group having important biological activity, and various commercial pesticide varieties contain oxazole rings, such as famoxadone (famoxadone), metamifop (metamifop), chlozolinate (chlozolinate) vinclozolin (vinclozolin), and the like, and have been widely used. Thus, the oxazole ring has important value for the research and development of new pesticides.
Based on an active substructure splicing strategy, the invention introduces an oxazole functional group into a phenazine mother nucleus structure for the first time, and adopts a simple, convenient and economic synthesis method to efficiently synthesize a series of phenazine compounds containing oxazole rings with novel structures. Through determination, the compounds have remarkable antibacterial activity and have the potential of being used as a novel agricultural bactericide for development and application.
Disclosure of Invention
The invention aims to provide a synthesis method of a novel phenazine compound containing an oxazole ring and application of the phenazine compound in plant disease control.
The phenazine compound containing oxazole ring provided by the invention has the following structural general formula:
wherein R is selected from: hydrogen, halogen, methyl, hydroxyl, amino, phenyl, phenoxy, difluoromethyl, trifluoromethyl, 1-6 carbon alkoxy, and 2-4 substituents represented by R. Wherein, the phenyl substituent group comprises phenyl and phenyl substituted by halogen, hydroxyl, amino and 1-6 carbon alkoxy.
The compound related to the invention can be synthesized by the following route and method, and is characterized by comprising the following four steps:
step 1: adding aniline compound A and 2-bromo-3-nitrobenzoic acid into 2, 3-butanediol, adding CuCl, Cu powder and N-ethylmorpholine, heating at 70 deg.C, stirring for 15 hr, washing the obtained solution with 0.1M ammonia water, and filtering. The resulting solution was slowly poured into 2M HCl to prepare intermediate B.
Step 2: intermediate B and NaBH 4 Adding the mixture into a solution in 2M NaOH, heating and refluxing for 5h, cooling in an ice bath after the reaction is finished to obtain the sodium salt of the phenazine acid, and then acidifying with dilute hydrochloric acid to obtain the phenazine-1-carboxylic acid intermediate C.
And step 3: and under the ice bath condition, dissolving the intermediate C in dichloromethane, dropwise adding oxalyl chloride and N, N-dimethylformamide under the protection of nitrogen, stirring at room temperature for 16h, removing volatile matters in vacuum, dissolving in dichloromethane, cooling to 0 ℃, dropwise adding ammonia water, stirring for half an hour, filtering a reactant to obtain a solid, drying, and recrystallizing with ethyl acetate to obtain the phenazine-1-formamide intermediate D.
And 4, step 4: heating the mixture of the intermediate D and 1, 3-dichloroacetone at 130 ℃ for 1h, cooling to room temperature, adding water for quenching, extracting the mixture with dichloromethane, drying an organic phase with sodium sulfate, filtering, concentrating under reduced pressure, and carrying out column chromatography to obtain the target compound.
The synthesis of the phenazine compound containing the oxazole ring provided by the invention has the characteristics of simple steps, high yield and easiness in operation.
The invention relates to a phenazine compound containing an oxazole ring, which preferably has the following structure:
the activity of the phenazine compound containing the oxazole ring on plant pathogenic fungi provided by the invention comprises Rhizoctonia solani (Rhizoctonia solani), pyricularia oryzae (Magnaporthe grisea), Rhizopus graminearum (Fusarium graminearum), Rhizoctonia cerealis (Gaeuanomyces graminis), Rhizoctonia cerealis (Rhizoctonia cerealis), Sclerotium sclerotiorum (Sclerotinia sclerotiorum), Phytophthora solani (Alternaria solani), Botryis cinerea (Botryis cinerea), Colletotrichum cucumeri (Colletotrichum lagenarium), Phytophthora solani (Phytophora infestans) and Phytophthora capsici (Phytophora capsici).
Detailed Description
The process of the present invention will be described below with reference to specific examples, but the present invention is not limited thereto. The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials may be prepared commercially or by conventional methods, unless otherwise specified.
The first embodiment is as follows: preparation of 2- (1-phenazine) -4-chloromethyl oxazole (Compound 1)
Respectively adding aniline and 2-bromo-3-nitrobenzoic acid into 2, 3-butanediol, adding CuCl, Cu powder and N-ethylmorpholine, heating and stirring at 70 ℃ for 15h, washing with 0.1M ammonia water, filtering, and slowly pouring the obtained solution into 2M HCl to obtain an intermediate 3-nitro-2-phenylaminobenzoic acid; adding the phenazine and NaBH4 into a solution in 2M NaOH, refluxing for 5h, cooling in an ice bath, and acidifying with dilute hydrochloric acid to obtain phenazine-1-carboxylic acid; under the ice bath condition, phenazine-1-carboxylic acid is dissolved in dichloromethane, oxalyl chloride and N, N-dimethylformamide are added dropwise under the protection of nitrogen, and the mixture is cooled to room temperatureStirring for 16h, removing volatile matters in vacuum, cooling to 0 ℃, dropwise adding ammonia water, stirring for half an hour, filtering the reactant to obtain a solid, drying, and recrystallizing with ethyl acetate to obtain phenazine-1-formamide; heating the mixture of the 2- (1-phenazine) -4-chloromethyl oxazole and 1, 3-dichloroacetone at 130 ℃ for 1h, cooling to room temperature, adding water for quenching, extracting the mixture with dichloromethane, drying an organic phase with sodium sulfate, filtering, concentrating under reduced pressure, and carrying out column chromatography to obtain the 2- (1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 68%. 1 H NMR(400MHz，CDCl 3 )δ8.53(dd，J＝7.0，1.4Hz，1H)，8.47(dd，J＝8.8，1.4Hz，1H)，8.38-8.35(m，1H)，8.34-8.31(m，1H)，8.00(s，1H)，7.96(dd，J＝8.7，7.0Hz，1H)，7.91(ddt，J＝9.1，6.6，3.3Hz，2H)，4.73(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：296.0591；found：296.0594。
The second embodiment: preparation of 2- (9-fluoro-1-phenazine) -4-chloromethyl oxazole (compound 2)
The preparation method is the same as the first embodiment. Substituting aniline with 2, 6-difluoroaniline to obtain 2- (9-fluoro-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 65%. 1 H NMR(400MHz，CDCl 3 )δ8.63(d，J＝7.1Hz，1H)，8.49(d，J＝2.4Hz，1H)，8.16(dt，J＝8.5，1.7Hz，2H)，8.04(d，J＝4.8Hz，1H)，7.91-7.87(m，1H)，7.64-7.58(m，1H)，4.74(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：314.0496；found：314.0499。
Example three: preparation of 2- (8-fluoro-1-phenazine) -4-chloromethyl oxazole (compound 3)
The preparation method is the same as the first embodiment. 2, 5-difluoroaniline is used for replacing aniline to obtain 2- (8-fluoro-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, 73% yield. 1 H NMR(400MHz，CDCl 3 )δ8.54(dd，J＝7.1，1.4Hz，1H)，8.43-8.37(m，2H)，8.23(d，J＝9.3Hz，1H)，8.03-7.93(m，2H)，7.84(dd，J＝9.3，2.1Hz，1H)，4.74(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：314.0496；found：314.0506。
Example four: preparation of 2- (7-fluoro-1-phenazine) -4-chloromethyl oxazole (compound 4)
The preparation method is the same as the first embodiment. The 4-fluoroaniline is used for replacing aniline to obtain 2- (7-fluoro-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 68%. 1 H NMR(400MHz，CDCl 3 )δ8.51(d，J＝7.1Hz，1H)，8.40(q，J＝7.7，6.6Hz，2H)，8.08-7.93(m，2H)，7.89(dd，J＝9.2，2.6Hz，1H)，7.72(t，J＝8.9Hz，1H)，4.74(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：314.0496；found：314.0499。
Example five: preparation of 2- (9-chloro-1-phenazine) -4-chloromethyl oxazole (compound 5)
The preparation method is the same as the first embodiment. 2-chloroaniline is used for replacing aniline to obtain 2- (9-chloro-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, 73% yield. 1 H NMR(400MHz，CDCl 3 )δ8.54(dd，J＝7.8，4.3Hz，2H)，8.31(d，J＝8.9Hz，1H)，8.18(s，1H)，8.01(s，1H)，7.97(dd，J＝8.7，7.1Hz，1H)，7.81(d，J＝8.9Hz，1H)，4.75(s，2H)，2.71(s，3H)。HRMS[ESI]m/z：calcd for([M+H] + )：330.0201；found：330.0197。
Example six: preparation of 2- (8-chloro-1-phenazine) -4-chloromethyl oxazole (compound 6)
The preparation method is the same as the first embodiment. Substituting aniline with 2-fluoro-5-chloroaniline to obtain 2- (8-chloro-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, 73% yield. 1 H NMR(400MHz，CDCl 3 )δ9.48(s，1H)，8.28(dd，J＝7.8，1.7Hz，1H)，8.17(dd，J＝8.2，1.7Hz，1H)，7.11-7.04(m，2H)，6.99(ddd，J＝8.8，4.2，2.5Hz，1H)，6.90(dd，J＝7.1，2.5Hz，1H)，5.07(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：330.0201；found：330.0201。
Example seven: preparation of 2- (7-chloro-1-phenazine) -4-chloromethyl oxazole (Compound 7)
The preparation method is the same as the first embodiment. Substituting aniline with 4-chloroaniline to obtain 2- (7-chloro-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 62%. 1 H NMR(400MHz，CDCl 3 )δ8.51(dd，J＝7.1，1.4Hz，1H)，8.38(dd，J＝8.7，1.4Hz，1H)，8.34-8.26(m，2H)，7.98(s，1H)，7.95(dd，J＝8.7，7.0Hz，1H)，7.81(dd，J＝9.2，2.3Hz，1H)，4.72(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：330.0201；found：330.0197。
Example eight: preparation of 2- (9-bromo-1-phenazine) -4-chloromethyl oxazole (compound 8)
The preparation method is the same as the first embodiment. 2-bromoaniline is used to replace aniline to obtain 2- (9-bromo-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 74%. 1 H NMR(400MHz，CDCl 3 )δ8.53(d，J＝7.0Hz，1H)，8.43(dd，J＝8.8，5.3Hz，1H)，8.40-8.34(m，1H)，8.31(q，J＝5.7Hz，1H)，8.01(s，1H)，7.96-7.88(m，2H)，4.74(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：373.9696；found：373.9692。
Example nine: preparation of 2- (8-bromo-1-phenazine) -4-chloromethyl oxazole (compound 9)
The preparation method is the same as the first embodiment. 2-fluoro-5-bromoaniline is used to replace aniline to obtain 2- (8-bromo-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 57%. 1 H NMR(400MHz，CDCl 3 )δ8.54(dd，J＝7.1，1.4Hz，1H)，8.43-8.37(m，2H)，8.23(d，J＝9.2Hz，1H)，8.04-7.93(m，2H)，7.84(dd，J＝9.3，2.2Hz，1H)，4.74(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：373.9696；found：373.9695。
Experimental example ten: preparation of 2- (7-bromo-1-phenazine) -4-chloromethyl oxazole (compound 10)
The preparation method is the same as the first embodiment. 4-bromoaniline is used to replace aniline to obtain 2- (7-bromo-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, 73% yield. 1 H NMR(400MHz，CDCl 3 )δ8.56-8.50(m，2H)，8.50-8.46(m，1H)，8.23(dd，J＝9.3，5.2Hz，1H)，7.99(d，J＝5.8Hz，2H)，7.97(s，1H)，4.74(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：373.9696；found：373.9693。
Example eleven: preparation of 2- (9-iodo-1-phenazine) -4-chloromethyloxazole (Compound 11)
The preparation method is the same as the first embodiment. 2-iodoaniline is used for replacing aniline to obtain 2- (9-iodine-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 65%. 1 H NMR(400MHz，CDCl 3 )δ8.53(d，J＝7.0Hz，1H)，8.46(d，J＝8.8Hz，1H)，8.35(dq，J＝18.0，4.8，3.4Hz，3H)，7.96(dd，J＝9.0，6.5Hz，2H)，4.75(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：421.9557；found：421.9548。
Example twelve: preparation of 2- (8-iodo-1-phenazine) -4-chloromethyloxazole (Compound 12)
The preparation method is the same as the first embodiment. 2-fluoro-3-iodoaniline is used to replace aniline to obtain 2- (8-iodo-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 75%. 1 H NMR(400MHz，CDCl 3 )δ9.48(s，1H)，8.28(dd，J＝7.8，1.7Hz，1H)，8.17(dd，J＝8.2，1.7Hz，1H)，7.11-7.03(m，2H)，6.99(ddd，J＝8.8，4.2，2.5Hz，1H)，6.90(dd，J＝7.1，2.5Hz，1H)，5.07(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：421.9557；found：421.9556。
Example thirteen: preparation of 2- (7-iodo-1-phenazine) -4-chloromethyloxazole (Compound 13)
The preparation method is the same as the first embodiment. The 4-iodoaniline is used for replacing aniline to obtain 2- (7-iodine-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 62%. 1 H NMR(400MHz，CDCl 3 )δ8.53(d，J＝5.9Hz，1H)，8.41(d，J＝10.3Hz，1H)，8.31(t，J＝6.1Hz，1H)，8.09(d，J＝5.3Hz，1H)，7.99(d，J＝10.3Hz，2H)，4.74(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：421.9557；found：421.9552。
Example fourteen: preparation of 2- (9-methyl-1-phenazine) -4-chloromethyl oxazole (compound 14)
The preparation method is the same as the first embodiment. 2- (9-methyl) aniline is replaced by 2-methylaniline to obtain 2- (9-methyl)-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 72%. 1 H NMR(400MHz，CDCl 3 )δ8.50-8.46(m，1H)，8.42(d，J＝8.7Hz，1H)，8.24(d，J＝8.9Hz，1H)，8.05(s，1H)，7.99(d，J＝1.1Hz，1H)，7.93(dd，J＝8.5，7.2Hz，1H)，7.73(dd，J＝9.0，1.8Hz，1H)，4.72(s，2H)，2.68(s，3H)。HRMS[ESI]m/z：calcd for([M+H] + )：310.0747；found：310.0748。
Example fifteen: preparation of 2- (8-methyl-1-phenazine) -4-chloromethyl oxazole (compound 15)
The preparation method is the same as the first embodiment. 2-fluoro-5-methylaniline is used for replacing aniline to obtain 2- (9-methyl-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 82%. 1 H NMR(400MHz，CDCl 3 )δ8.54(dd，J＝7.8，4.3Hz，2H)，8.31(d，J＝8.9Hz，1H)，8.18(s，1H)，8.03-7.94(m，2H)，7.81(d，J＝8.9Hz，1H)，4.75(s，2H)，2.71(s，3H)。HRMS[ESI]m/z：calcd for([M+H] + )：310.0747；found：310.0748。
Example sixteen: preparation of 2- (7-methyl-1-phenazine) -4-chloromethyl oxazole (compound 16)
The preparation method is the same as the first embodiment. Substituting aniline with 4-methylaniline to obtain 2- (7-methyl-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 76%. 1 H NMR(400MHz，CDCl 3 )δ8.48(dd，J＝6.8，1.2Hz，1H)，8.42(d，J＝8.7Hz，1H)，8.24(d，J＝8.9Hz，1H)，8.05(s，1H)，7.99(s，1H)，7.93(dd，J＝8.5，7.2Hz，1H)，7.73(dd，J＝9.0，1.8Hz，1H)，4.72(s，2H)，2.68(s，3H)。HRMS[ESI]m/z：calcd for([M+H] + )：310.0747；found：310.0747。
Example seventeen: preparation of 2- (9-methoxy-1-phenazine) -4-chloromethyl oxazole (compound 17)
The preparation method is the same as the first embodiment. 2-methoxyaniline is used for replacing aniline to obtain 2- (9-methoxy-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 75%. 1 H NMR(400MHz，CDCl 3 )δ8.98(d，J＝7.1Hz，1H)，8.46(d，J＝8.8Hz，1H)，8.28(d，J＝9.5Hz，1H)，8.01(t，J＝7.9Hz，1H)，7.70-7.61(m，1H)，7.54(d，J＝2.8Hz，1H)，5.32(s，1H)，4.97(s，2H)，4.10(s，3H)。HRMS[ESI]m/z：calcd for([M+H] + )：326.0696；found：326.0692。
Example eighteen: preparation of 2- (8-methoxy-1-phenazine) -4-chloromethyl oxazole (compound 18)
The preparation method is the same as the first embodiment. 2-fluoro-5-methoxyaniline is used for replacing aniline to obtain 2- (8-methoxy-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 62%. 1 H NMR(400MHz，CDCl 3 )δ8.54(d，J＝7.0Hz，1H)，8.46-8.40(m，1H)，8.32(s，2H)，8.02-7.96(m，2H)，7.84(d，J＝8.9Hz，1H)，4.75(s，2H)。HRMS[ESI]m/z：calcd for([M+H]+)：326.0696；found：326.0693。
Example nineteenth: preparation of 2- (7-methoxy-1-phenazine) -4-chloromethyl oxazole (compound 19)
The preparation method is the same as the first embodiment. 4-methoxyaniline is used for replacing aniline to obtain 2- (7-methoxy-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 70%. 1 H NMR(400MHz，CDCl 3 )δ8.98(d，J＝7.1Hz，1H)，8.46(d，J＝8.8Hz，1H)，8.28(d，J＝9.5Hz，1H)，8.01(t，J＝7.9Hz，1H)，7.68-7.63(m，1H)，7.54(s，1H)，6.04(s，1H)，4.97(s，2H)，4.10(s，3H)。HRMS[ESI]m/z：calcd for([M+H] + )：326.0696；found：326.0697。
Example twenty: preparation of 2- (7-phenyl-1-phenazine) -4-chloromethyl oxazole (compound 20)
The preparation method is the same as the first embodiment. Substituting 4-benzidine for aniline to obtain 2- (7-phenyl-1-phenazine) -4-chloromethyl oxazole. Yellow liquid, yield 85%. 1 H NMR(400MHz，CDCl 3 )δ8.28-8.16(m，2H)，7.62-7.52(m，4H)，7.49-7.41(m，2H)，7.40-7.32(m，1H)，7.13-7.05(m，2H)，7.02(t，J＝8.0Hz，1H)，4.94(s，2H)。HRMS[ESI]m/z：calcd for([M+H] + )：372.0904；found：372.0899。
Example twenty one: determination of antibacterial activity of phenazine compound containing oxazole ring
The in vitro antibacterial activity evaluation is carried out by adopting a plate hypha growth rate inhibition method, and test strains are selected to be activated on a PDA plate, wherein the test strains comprise Rhizoctonia solani (Rhizoctonia solani), rice blast fungus (Magnaporthe grisea), wheat gibberellic disease (Fusarium graminearum), wheat holomyces graminis (Gaeumannomyces graminis), wheat Rhizoctonia cerealis (Rhizoctonia cerealis), Sclerotinia sclerotiorum (Sclerotinia sclerotiorum), tomato early blight (Alternaria solani), tomato gray mold (Botryis cinerea), cucumber Colletotrichum (Colletochium laxum), potato late blight (Phytophora infestans) and pepper fungus (Phytophtora capsici).
Preparing the compound into a PDA drug-containing flat plate with the concentration of 20 mu g/mL, preparing a bacterial cake with the diameter of 5mm from a test strain, placing the bacterial cake in the center of a drug-containing culture dish, culturing at the constant temperature of 25 ℃ until the test strain in a blank control dish grows to be close to the edge of the culture dish, measuring the colony diameter of each drug-containing flat plate by using a cross method, repeating for 3 times, calculating the average value, and comparing with the blank control to calculate the relative bacteriostasis rate. The inhibition rate of the disease is calculated according to the following formula:
further preparing the compound into PDA drug-containing flat plate with gradient concentration, obtaining the bacteriostatic rate by the same method, and calculating the concentration of the compound when the inhibitory rate is 50%, namely EC by using SPSS 20.0 statistical software 50 The value is obtained. Phenazine-1-carboxylic acid (shenqinmycin), Phenamacril (Phenamacril) and Carbendazim (Carbendazim) were used as positive controls.
TABLE 1 inhibitory ratio (%)% of phenazine compound containing oxazole ring at 20. mu.g/mL concentration to phytopathogen
TABLE 2 EC of phenazine compound containing oxazole ring on plant pathogenic bacteria 50 Value of
As can be seen from tables 1 and 2, the phenazine compound containing the oxazole ring has a certain inhibition effect on the growth of three plant pathogenic fungi, and the bacteriostatic activity of the compound is obviously improved compared with that of a commercial pesticide phenazine-1-carboxylic acid (shenqinmycin). Wherein the inhibition medium concentration of the compounds 4, 14 and 17 to sclerotinia sclerotiorum is less than 1.0 mu g/mL, and is close to positive control carbendazim (EC) 50 Equal to 0.33 mug/mL) and better than another positive control phenamacril (EC) 50 7.83 μ g/mL). Therefore, the compounds have the potential of further development and application as novel agricultural bactericides.
The use of the phenazine compounds containing an oxazole ring as agricultural fungicides of the present invention has been described by way of specific examples, and those skilled in the art can refer to the present invention and appropriately modify the raw materials, process conditions, etc. to achieve other objects without departing from the present invention, and all such substitutions and modifications will be obvious to those skilled in the art and are intended to be included within the scope of the present invention.
Claims (6)
1. A phenazine compound containing oxazole ring is characterized in that the phenazine compound has the following general formula:
wherein R is selected from: hydrogen, halogen, methyl, hydroxyl, amino, phenyl, phenoxy, difluoromethyl, trifluoromethyl, 1-6 carbon alkoxy, and 2-4 substituents represented by R.
2. A phenazine compound containing an oxazole ring as set forth in claim 1, which comprises the following compounds:
3. the use of the phenazine compounds containing an oxazole ring as claimed in claim 1 for controlling agricultural plant diseases.
4. The use of claim 3, wherein the agricultural plant disease is rice sheath blight disease, sclerotinia rot of colza, wheat scab.
5. The use according to claim 3 or 4, wherein the compound is formulated as emulsifiable concentrate, aqueous emulsion, microemulsion, wettable powder, water dispersible granule, suspension or other suitable dosage forms.
6. The application of the phenazine compound containing the oxazole ring in preventing and treating agricultural plant diseases according to claim 1 or 2, which is characterized in that the phenazine compound is combined with one or more of commercial bactericides to prepare compound bactericides; the commercial fungicide is selected from azoxystrobin, pyraclostrobin, prothioconazole, mancozeb, epoxiconazole, tebuconazole, prochloraz, boscalid, fluopicolide, metalaxyl, difenoconazole, propiconazole, chlorothalonil, validamycin, carbendazim and cyazoxystrobin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910956284.4A CN110551117B (en) | 2019-10-09 | 2019-10-09 | Phenazine compound containing oxazole ring and application of phenazine compound as agricultural bactericide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910956284.4A CN110551117B (en) | 2019-10-09 | 2019-10-09 | Phenazine compound containing oxazole ring and application of phenazine compound as agricultural bactericide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110551117A CN110551117A (en) | 2019-12-10 |
| CN110551117B true CN110551117B (en) | 2022-09-27 |
Family
ID=68742487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910956284.4A Active CN110551117B (en) | 2019-10-09 | 2019-10-09 | Phenazine compound containing oxazole ring and application of phenazine compound as agricultural bactericide |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110551117B (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3558984T3 (en) * | 2016-12-20 | 2024-01-15 | Fmc Corporation | Fungicidal oxadiazoles |
| CN107188858B (en) * | 2017-06-12 | 2021-05-04 | 长江大学 | Phenazine-1-formyl piperazine compound and application thereof |
| CN107382988B (en) * | 2017-07-10 | 2020-10-09 | 长江大学 | 2-substituted sulfenyl-5- (1-phenazinyl) -1,3, 4-oxadiazole compound and application thereof |
-
2019
- 2019-10-09 CN CN201910956284.4A patent/CN110551117B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN110551117A (en) | 2019-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1993328B (en) | Quinoline derivative and insecticide containing same as active constituent | |
| US4877441A (en) | Fungicidal substituted carboxylic acid derivatives | |
| JP2006290883A (en) | Substituted heterocycle carboxylic anilide derivative, its intermediate and chemical for agriculture and horticulture and method for using the same | |
| TWI532431B (en) | Ethynylphenylamidine compound or a salt thereof, a method for producing the same, and a fungicide for agricultural and horticulture | |
| CN105330644B (en) | （The base of 1,2,3,4 tetrahydroquinoline 1）（Substituted pyrazolecarboxylic base）First ketone compounds and its application | |
| US8865724B2 (en) | Preparation of 2-methyl-4-amino-5(substituted-1H-1,2,3-triazolyl)methylpyrimidine derivatives and microbicidal activity thereof | |
| CN109467533A (en) | A kind of 8-hydroxyquinoline class compound and preparation method thereof and the purposes in prevention and treatment agricultural disease | |
| CN111875559A (en) | Thiazole hydrazide derivatives and application thereof as agricultural bactericide | |
| CN110551117B (en) | Phenazine compound containing oxazole ring and application of phenazine compound as agricultural bactericide | |
| CN107459490B (en) | Phenazine-1-carboxamides and their use | |
| CN111377870B (en) | 2, 4-dioxoimidazolines cyclohexane sulfonamide compounds, process for their preparation and their use as fungicides or bactericides | |
| CN110372622A (en) | Phenyl acetanides containing chiral oxazoline and the purposes as disinfectant use in agriculture | |
| CN105418504B (en) | The pyrazolecarboxamide compounds of the base containing diaryl-amine and its application in agricultural chemicals | |
| CN109384722B (en) | N-substituted amide compound, preparation method and application thereof, and bactericide | |
| CN115636795B (en) | Preparation method of quinazolinone derivative containing thiobenzamide structure and composition thereof, and application of quinazolinone derivative and composition thereof in preventing and treating kiwi fruit canker | |
| CN108440412B (en) | 2-pyrazole amide cyclohexyl sulfonamide compound, preparation method and application thereof | |
| CN114213311B (en) | Substituted benzaldehyde oxime ester compound and preparation method and application thereof | |
| CN107721956B (en) | Benzobutyrolactone derivative, synthesis method and application thereof in preparing bactericide | |
| CN103864662A (en) | Pyrrolidine diones-containing methoxy methyl acrylate compound, preparation method and application thereof | |
| CN107721997B (en) | Thiadiazole thiazolinone compound and preparation method and application thereof | |
| CN110437099B (en) | Aromatic hydrazide compound and preparation method and application thereof | |
| CN106431977B (en) | A kind of unsaturated oximido ethers compound and application thereof | |
| CN107536835A (en) | Application and medicine of 1,3 diaminourea 7H pyrroles [3,2 f] quinazoline derivant as antibacterials | |
| CN114835696B (en) | Phthalide hydrazide compound and preparation method and application thereof | |
| CN108440510A (en) | A kind of acid amide fungicides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |